financetom
Business
financetom
/
Business
/
Brazilian investor Tanure names just 1 GPA board member, not 3
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Brazilian investor Tanure names just 1 GPA board member, not 3
May 26, 2025 1:20 AM

May 5 (Reuters) - An investment fund controlled by

Brazilian investor Nelson Tanure decided to appoint just one

member to the board of retail chain Grupo Pao de Açucar (GPA) at

a shareholder meeting on Monday.

"We chose to elect only one independent candidate whom we

trust, with deep knowledge of the retail market, as a way to

protect our investment, given the difficult scenario we foresee

for GPA," Tanure told Reuters.

Tanure, who now owns about 7% of GPA's shares,

had requested the removal of the previous board of directors

earlier this year and election of new members, including three

representatives appointed by him.

However, other groups of investors who were not represented

on the board decided to appoint members as well, diluting

support for Tanure's appointees. This motivated him to withdraw

the names of two other people he had nominated, a source with

knowledge of the matter told Reuters earlier on Monday.

GPA did not immediately respond to a request for comment.

Last year, Tanure acquired GPA shares on the market and has

since been interested in buying additional securities from

French group Casino, as Reuters reported in March.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Singapore's top bank DBS eyes $370 billion in wealth assets by 2026, top exec says
Singapore's top bank DBS eyes $370 billion in wealth assets by 2026, top exec says
Jun 12, 2024
By Yantoultra Ngui SINGAPORE (Reuters) - DBS Group plans to boost assets under management for its wealth business to S$500 billion ($369.7 billion) by the end of 2026, said the unit's head, as the top Singaporean bank bets on robust inflows into the city state. Wealth assets at DBS grew 23% to a record S$365 billion last year, as Singapore...
Lendway Names Co-Chief Executives Following Randy Uglem's Resignation
Lendway Names Co-Chief Executives Following Randy Uglem's Resignation
Jun 12, 2024
04:29 AM EDT, 06/12/2024 (MT Newswires) -- Lendway ( LDWY ) said late Tuesday it has appointed Mark Jundt and Daniel Philp as co-chief executive officers, effective July 1. The specialty ag and finance company said Jundt has been a board member since November 2022 and chairman from August 2023. Meanwhile, Philp has been a board member since November 2022....
Ultragenyx, Mereo BioPharma Say Phase 2 Study of Bone Disorder Drug Showed Reduced Fracture Rate
Ultragenyx, Mereo BioPharma Say Phase 2 Study of Bone Disorder Drug Showed Reduced Fracture Rate
Jun 12, 2024
04:44 AM EDT, 06/12/2024 (MT Newswires) -- Ultragenyx Pharmaceutical ( RARE ) and Mereo BioPharma Group ( MREO ) said late Tuesday a phase 2 study of setrusumab showed ongoing and meaningful improvements in the lumbar spine bone mineral density of patients with osteogenesis imperfecta. The drug companies said the phase 2 portion of an ongoing phase 2/3 study showed...
Belite Bio Obtains Pioneer Drug Designation for Stargardt Disease Treatment in Japan
Belite Bio Obtains Pioneer Drug Designation for Stargardt Disease Treatment in Japan
Jun 12, 2024
04:54 AM EDT, 06/12/2024 (MT Newswires) -- Belite Bio ( BLTE ) said Wednesday its oral tablet tinlarebant for the treatment of Stargardt disease has secured Sakigake, or pioneer drug designation, by the Ministry of Health, Labor and Welfare in Japan. Sakigake designation is intended to accelerate the drug approval process in Japan for innovative drugs with prominent effectiveness targeting...
Copyright 2023-2026 - www.financetom.com All Rights Reserved